BDBM50070010 4-((2R,3R)-1-Benzylcarbamoyl-3-methyl-4-oxo-azetidin-2-yloxy)-benzoic acid::CHEMBL122575

SMILES C[C@@H]1[C@@H](Oc2ccc(cc2)C(O)=O)N(C(=O)NCc2ccccc2)C1=O

InChI Key InChIKey=BRYGRWNTDBRNDJ-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50070010   

TargetChymotrypsinogen A(Bovine)
Glaxo Wellcome Research and Development

Curated by ChEMBL
LigandPNGBDBM50070010(4-((2R,3R)-1-Benzylcarbamoyl-3-methyl-4-oxo-azetid...)
Affinity DataIC50: 1.60E+3nMAssay Description:Concentration required to inhibit the mammalian Chymotrypsinogen by 50% was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-5)
Glaxo Wellcome Research and Development

Curated by ChEMBL
LigandPNGBDBM50070010(4-((2R,3R)-1-Benzylcarbamoyl-3-methyl-4-oxo-azetid...)
Affinity DataIC50: 2.00E+4nMAssay Description:Concentration required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Glaxo Wellcome Research and Development

Curated by ChEMBL
LigandPNGBDBM50070010(4-((2R,3R)-1-Benzylcarbamoyl-3-methyl-4-oxo-azetid...)
Affinity DataIC50: 1.00E+5nMAssay Description:Concentration required to inhibit the mammalian Acetylcholinesterase by 50% was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed